Lambert Potin
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lymphatic System and Diseases
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 11
- Lymphatic System and Diseases 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 6
- Co-authors
- Melody A. Swartz (13 shared papers)Jun Ishihara (5 shared papers)Jeffrey A. Hubbell (5 shared papers)Peyman Hosseinchi (5 shared papers)Ako Ishihara (4 shared papers)Aslan Mansurov (3 shared papers)John‐Michael Williford (3 shared papers)Kazuto Fukunaga (3 shared papers)
- Journals
- Science Translational Medicine (3 papers)The Journal of Experimental Medicine (2 papers)Molecular Cancer Therapeutics (1 paper)The Journal of Immunology (1 paper)Nature Biomedical Engineering (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Lambert Potin
14 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Immunology 636
- Oncology 705
- Immunology and Allergy 55
- Biotechnology 53
- Molecular Biology 381
Countries citing papers authored by Lambert Potin
This map shows the geographic impact of Lambert Potin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambert Potin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambert Potin more than expected).
Fields of papers citing papers by Lambert Potin
This network shows the impact of papers produced by Lambert Potin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambert Potin. The network helps show where Lambert Potin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lambert Potin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 192 | |
| 2 | 2017 | 190 | |
| 3 | 2020 | 178 | |
| 4 | 2019 | 147 | |
| 5 | 2017 | 135 | |
| 6 | 2019 | 99 | |
| 7 | 2019 | 99 | |
| 8 | 2017 | 87 | |
| 9 | 2018 | 36 | |
| 10 | 2012 | 22 | |
| 11 | 2020 | 13 | |
| 12 | 2023 | 2 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 1 |
About Lambert Potin
Lambert Potin is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers), Systemic Sclerosis and Related Diseases (2 papers), Extracellular vesicles in disease (2 papers), Vascular Malformations and Hemangiomas (2 papers) and Lymphatic Disorders and Treatments (2 papers). The work is most often cited by research in Immunology (636 citations), Oncology (705 citations), Immunology and Allergy (55 citations), Biotechnology (53 citations) and Molecular Biology (381 citations). Lambert Potin has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Melody A. Swartz, Jun Ishihara, Jeffrey A. Hubbell, Peyman Hosseinchi, Ako Ishihara, Aslan Mansurov, John‐Michael Williford, Kazuto Fukunaga, Tiffany M. Marchell and Katharina Maisel. Their work appears in journals such as Science Translational Medicine, The Journal of Experimental Medicine, Molecular Cancer Therapeutics, The Journal of Immunology and Nature Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.